ADVERTISEMENT
to multiple media reports. Endpoints News first reported the development, and The Washington Post cited three people familiar with the matter who confirmed Hemmati is under consideration. FDA Commissioner Marty Makary is said to favor Hemmati for the role, according to two of the people familiar with the discussions. However, a final decision has not continue reading …
ADVERTISEMENT